A new study published in the journal Stem Cell Reports by University of Alberta researchers is shedding light on why many COVID-19 patients, even those not in hospital, are suffering from hypoxia–a potentially dangerous condition in which there is decreased oxygenation in the body’s tissues. The study also shows why the anti-inflammatory drug dexamethasone has been an effective treatment for those with the virus.
New study may help explain low oxygen levels in COVID-19 patients
June 2, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022